Johnson B, Lader S
Br J Clin Pharmacol. 2012; 1(4):329-33.
PMID: 22454888
PMC: 1402428.
DOI: 10.1111/j.1365-2125.1974.tb00262.x.
Achong M, Kumana C
Can Fam Physician. 2011; 28:97-100.
PMID: 21289849
PMC: 2306300.
Lee C, Park Y, Sands C, Jones D, Trang J
Arch Pharm Res. 1994; 17(2):80-6.
PMID: 10319136
DOI: 10.1007/BF02974228.
Steinberg C, Notterman D
Clin Pharmacokinet. 1994; 27(5):345-67.
PMID: 7851053
DOI: 10.2165/00003088-199427050-00003.
Ochs H, BODEM G, Greenblatt D
Eur J Clin Pharmacol. 1981; 19(1):53-5.
PMID: 7461024
DOI: 10.1007/BF00558384.
Drug interactions with digoxin.
Brown D, Spector R, Juhl R
Drugs. 1980; 20(3):198-206.
PMID: 7428668
DOI: 10.2165/00003495-198020030-00003.
Pharmacokinetics and dosagae of digoxin in neonates and infants.
Nyberg L, Wettrell G
Eur J Clin Pharmacol. 1980; 18(1):69-74.
PMID: 7398751
DOI: 10.1007/BF00561481.
Clinical implications of serum digoxin concentrations.
Ochs H, Greenblatt D, Harmatz J, BODEM G, DENGLER H
Klin Wochenschr. 1981; 59(10):501-7.
PMID: 7241950
DOI: 10.1007/BF01696212.
A standard approach to compiling clinical pharmacokinetic data.
Sheiner L, Benet L, Pagliaro L
J Pharmacokinet Biopharm. 1981; 9(1):59-127.
PMID: 7014827
DOI: 10.1007/BF01059343.
Effect of quinidine on digoxin bioavailability.
Pedersen K, Christiansen B, Klitgaard N, Nielsen-Kudsk F
Eur J Clin Pharmacol. 1983; 24(1):41-7.
PMID: 6832200
DOI: 10.1007/BF00613925.
[Bioavailability of digoxin in fixed combinations (author's transl)].
Ochs H, BODEM G, DENGLER H
Klin Wochenschr. 1974; 52(13):637-9.
PMID: 4848130
DOI: 10.1007/BF01468799.
How to digitalize and to maintain optimal digoxin levels in congestive heart failure.
Lambert C, Rouleau J
Cardiovasc Drugs Ther. 1989; 2(6):717-26.
PMID: 2488083
DOI: 10.1007/BF00133199.
Bioavailability studies with Digoxin-Sandoz and Lanoxin.
Beveridge T, Kalberer F, Nuesch E, Schmidt R
Eur J Clin Pharmacol. 1975; 8(5):371-6.
PMID: 1243983
DOI: 10.1007/BF00562665.
Absorption of digoxin in infants.
Wettrell G, Andersson K
Eur J Clin Pharmacol. 1975; 9(1):49-55.
PMID: 1233252
DOI: 10.1007/BF00613428.
Effect of particle size on the bioavailability of digoxin.
Jounela A, Pentikainen P, Sothmann A
Eur J Clin Pharmacol. 1975; 8(5):365-70.
PMID: 1233237
DOI: 10.1007/BF00562664.
[Bioavailability of beta-acetyldigoxin and digoxin (author's transl)].
Flasch H
Klin Wochenschr. 1975; 53(18):873-7.
PMID: 1172599
DOI: 10.1007/BF01466961.
[Comparison of digitoxin bioavailability from tablets and elixir during maintenance therapy (author's transl)].
Ochs H, BODEM G, Hahn E, DENGLER H
Klin Wochenschr. 1975; 53(9):425-9.
PMID: 1152354
DOI: 10.1007/BF01493367.
[Radioimmunological estimation of digoxin in urine (author's transl)].
Maertin K, Rietbrock N
Klin Wochenschr. 1977; 55(9):429-38.
PMID: 875316
DOI: 10.1007/BF01488580.
Correlation of digoxin-tablet dissolution-rate with biological availability.
REISSELL P, Ojala K, Manninen V, Sothman A
Br J Clin Pharmacol. 1977; 4(2):235-6.
PMID: 861138
PMC: 1429011.
DOI: 10.1111/j.1365-2125.1977.tb00700.x.
Pharmacokinetics in patients with cardiac failure.
Benowitz N, Meister W
Clin Pharmacokinet. 1976; 1(6):389-405.
PMID: 799548
DOI: 10.2165/00003088-197601060-00001.
